Australia markets closed

Dermapharm Holding SE (DMPHF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
42.680.00 (0.00%)
At close: 04:05PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
1,135,351
1,135,351
1,024,776
942,912
793,829
Cost of revenue
416,191
416,191
363,943
322,218
330,348
Gross profit
719,160
719,160
660,833
620,694
463,481
Operating expenses
Research development
10,628
10,628
13,178
14,174
12,662
Selling general and administrative
95,283
95,283
66,748
65,882
66,609
Total operating expenses
539,059
539,059
418,784
333,651
318,211
Operating income or loss
180,101
180,101
242,049
287,043
145,270
Interest expense
54,968
54,968
12,338
8,837
9,362
Income before tax
105,997
105,997
216,297
292,977
125,283
Income tax expense
45,462
45,462
83,680
84,073
39,357
Income from continuing operations
60,534
60,534
132,617
208,904
85,926
Net income
62,368
62,368
134,236
209,583
85,826
Net income available to common shareholders
62,368
62,368
134,236
209,583
85,826
Basic EPS
1.76
1.16
2.49
3.89
1.59
Diluted EPS
1.76
1.16
2.49
3.89
1.59
Basic average shares
53,828
53,840
53,840
53,840
53,840
Diluted average shares
53,828
53,840
53,840
53,840
53,840